Supporting Information

Similar documents
1,5-Electrocyclization of conjugated azomethine ylides derived from 3-formyl chromene and N-alkyl amino acids/esters

C-N and C-P bond formation via cross dehydrative coupling reaction: an efficient synthesis of novel 3,4-dihydroquinazolines

Lewis acid-catalyzed regioselective synthesis of chiral α-fluoroalkyl amines via asymmetric addition of silyl dienolates to fluorinated sulfinylimines

Synthesis and Blastocyst Implantation Inhibition Potential of Lupeol Derivatives in Female Mice

A pillar[2]arene[3]hydroquinone which can self-assemble to a molecular zipper in the solid state

Supporting Information

Supporting Information for. Boronic Acid Functionalized Aza-Bodipy (azabdpba) based Fluorescence Optodes for the. analysis of Glucose in Whole Blood

Copper(II) Ionic Liquid Catalyzed Cyclization-Aromatization of. Hydrazones with Dimethyl Acetylenedicarboxylate: A Green Synthesis

Electronic Supplementary Information (ESI) belonging to

Zinc Chloride Promoted Formal Oxidative Coupling of Aromatic Aldehydes and Isocyanides to α- Ketoamides

Rameshwar Prasad Pandit and Yong Rok Lee * School of Chemical Engineering, Yeungnam University, Gyeongsan , Korea

Masatoshi Shibuya,Takahisa Sato, Masaki Tomizawa, and Yoshiharu Iwabuchi* Department of Organic Chemistry, Graduate School of Pharmaceutical Sciences,

p-toluenesulfonic Acid-Mediated 1,3-Dipolar Cycloaddition of

Schwartz s reagent-mediated regiospecific synthesis of 2,3-disubstituted indoles from isatins

Supplementary Information

Supporting Materials. Experimental Section. internal standard TMS (0 ppm). The peak patterns are indicated as follows: s, singlet; d,

Supporting Information Synthesis of 2-Aminobenzonitriles through Nitrosation Reaction and Sequential Iron(III)-Catalyzed C C Bond Cleavage of 2-Arylin

Highly efficient hydrazination of conjugated nitroalkenes via imidazole or DMAP mediated Morita-Baylis-Hillman reaction

Supplementary Information

Pyridazine N-Oxides as Precursors of Metallocarbenes: Rhodium-Catalyzed Transannulation with Pyrroles. Supporting Information

Supporting Information. Efficient copper-catalyzed Michael addition of acrylic derivatives with primary alcohols in the presence of base

Catalyst-free chemoselective N-tert-butyloxycarbonylation of amines in water

ph Switchable and Fluorescent Ratiometric Squarylium Indocyanine Dyes as Extremely Alkaline Sensors

Supporting Information

Stereoselective Aza-Darzens Reactions of Tert- Butanesulfinimines: Convenient Access to Chiral Aziridines

Preparation of Fluorinated Tetrahydropyrans and Piperidines using a New Nucleophilic Fluorination Reagent DMPU/HF

An Unusual Glycosylation Product from a Partially Protected Fucosyl Donor. under Silver Triflate activation conditions. Supporting information

Supporting Information

NHC-catalyzed cleavage of vicinal diketones and. triketones followed by insertion of enones and

Electronic Supplementary Information (ESI)

Supporting Information. Palladium-Catalyzed Formylation of Aryl Iodides with HCOOH as

Nitro-Grela-type complexes containing iodides. robust and selective catalysts for olefin metathesis

Supporting Information. Copper-catalyzed cascade synthesis of benzimidazoquinazoline derivatives under mild condition

Regioective Halogenation of 2-Substituted-1,2,3-Triazole via sp 2 C-H Activation

Supporting Information. Use of Potassium. -Trifluoroborato Amides in Suzuki-Miyaura. Cross-Coupling Reactions

Supplementary Information. Intramolecular 5-exo, 7-endo-dig Transition Metal-Free Cyclization

metal-organic compounds

Electronic Supplementary Information. Quinine/Selectfluor Combination Induced Asymmetric Semipinacol Rearrangement of

Supporting Information

Supporting information

Synthetic chemistry-led creation of a difluorinated biaryl ether non-nucleoside reverse transcriptase inhibitor

Electronic Supplementary Information

Supplementary Materials Contents

Supporting Information

Direct Synthesis of a Copper(II) N-heterocyclic Carbene Complex in Air

Supporting Information for. Use of the Curtius Rearrangement of Acryloyl Azides in the Synthesis of. 3,5-Disubstituted Pyridines: Mechanistic Studies

The First Au-Nanoparticles Catalyzed Green Synthesis of Propargylamines Via Three-Component Coupling Reaction of Aldehyde, Alkyne And Amine

One-pot Synthesis of 1-Alkyl-1H-indazoles. Supporting Information

Supporting Information. Radical fluorination powered expedient synthesis of 3 fluorobicyclo[1.1.1]pentan 1 amine

Experimental. Crystal data

Novel D-erythro N-Octanoyl Sphingosine Analogs As Chemo- and Endocrine. Resistant Breast Cancer Therapeutics

Supporting Information. An Efficient Synthesis of Optically Active Physostigmine from Tryptophan via Alkylative Cyclization

Supporting Information

Ruthenium-Catalyzed C H Oxygenation on Aryl Weinreb Amides

Supporting Information

Direct ortho-c H Functionalization of Aromatic Alcohols Masked by Acetone Oxime Ether via exo-palladacycle

Efficient Metal-Free Pathway to Vinyl Thioesters with Calcium Carbide as the Acetylene Source

Supporting Information

SUPPORTING INFORMATION. Transition metal-promoted synthesis of 2-aryl/heteroaryl-thioquinazoline: C-S

Cu-Catalyzed Direct C6-Arylation of Indoles

Experimental. Crystal data

Experimental. Crystal data. C 32 H 25 NO 5 M r = Monoclinic, C2=c a = (6) Å b = (2) Å c = (3) Å = 96.

Experimental. Crystal data. C 19 H 19 N 3 O 3 M r = Monoclinic, C2=c a = (3) Å b = (2) Å c = (3) Å = 110.

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein

Supplemental Material

Thiol-Activated gem-dithiols: A New Class of Controllable. Hydrogen Sulfide (H 2 S) Donors

organic compounds N-Cinnamoyl-L-phenylalanine methyl ester Related literature References Experimental

Development of a near-infrared fluorescent probe for monitoring hydrazine in serum and living cells

Synthesis of the trans-hydrindane core of dictyoxetane

Supporting Information

Fluorescent probes for detecting monoamine oxidase activity and cell imaging

Methyltrioxorhenium-Catalyzed Highly Selective Dihydroxylation of 1,2-Allenylic Diphenyl Phosphine Oxides

Preparation of Stable Aziridinium Ions and Their Ring Openings

Eur. J. Org. Chem WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2007 ISSN X SUPPORTING INFORMATION

by Donor-Acceptor Complex

Divergent Construction of Pyrazoles via Michael Addition of N-Aryl Hydrazones to 1,2-Diaza-1,3-dienes

Supporting Information

Experimental. Crystal data

Supporting Information

Base-promoted acetal formation employing aryl salicylates

Supporting Information

Supporting information for. Synthesis of phenothiazines from cyclohexanones and. 2-aminobenzenethiols under transition-metal-free conditions

CDI Mediated Monoacylation of Symmetrical Diamines and Selective Acylation of Primary Amines of Unsymmetrical Diamines

b = (17) Å c = (18) Å = (4) = (4) = (4) V = (3) Å 3 Data collection Refinement

Supporting Information. for. Access to pyrrolo-pyridines by gold-catalyzed. hydroarylation of pyrroles tethered to terminal alkynes

Electronic Supplementary Information

Enantioselective synthesis of anti- and syn-β-hydroxy-α-phenyl carboxylates via boron-mediated asymmetric aldol reaction

Allenylphosphine oxides as simple scaffolds for. phosphinoylindoles and phosphinoylisocoumarins

Electronic Supplementary Information

Supporting Information

Catalytic decarboxylative alkylation of β-keto acids with sulfonamides via the cleavage of carbon nitrogen and carbon carbon bonds

Supporting Information

Supporting Information

= (3) = (3) = (4) V = (4) Å 3 Z =2. Data collection. Refinement

Ynamides as racemization-free coupling reagents for amide and peptide synthesis

Support Information. Table of contents. Experimental procedures. S2. Spectroscopic data... S2-S23. Photophysical properties..

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 326 parameters 2 restraints

Supporting Information

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity

Experimental. Crystal data. C 20 H 23 N 4 O 6 PS M r = Monoclinic, P2 1 =n a = (2) Å b = (4) Å c = (2) Å = 117.

Transcription:

Supporting Information A Regioselective Ring-Expansion of Isatins with In-situ Generated α-aryldiazomethanes; Direct Access to Viridicatin Alkaloids Yellaiah Tangella,, Kesari Lakshmi Manasa,, Namballa Hari Krishna,, B. Sridhar, Ahmed Kamal*,, and Bathini Nagendra Babu*,,, Fluoro-Agrochemicals, Centre for X-ray Crystallography, CSIR-Indian Institute of Chemical Technology, Hyderabad- 500 007, India Academy of Scientific and Innovative Research (AcSIR), New Delhi 110025, India Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad-500 037, India. School of Pharmaceutical Education and Research (SPER), Jamia Hamdard University, New Delhi-110062, India Email: bathini@iict.res.in Contents General information..s2 X-ray crystal structure and crystal data of 4j S2 References..S3 General procedure for the synthesis of 4 and 5.S4 Characterization data for compounds 4 and 5..S4 Procedure and characterization data for the synthesis of 6, 7 and 8 S19 Copies of 1 H NMR and 13 C NMR spectra of 4, 5, 6, 7 and 8..S21 1

General Information All solvents and reagents were purchased from commercial suppliers and used without any further purification. The methyl- and benzyl- protected isatins were prepared according to the literature. All the reagents were handled and weighed in the air at room temperature. Thin layer chromatography (TLC) was performed using pre-coated silica gel 60 F254 MERCK. TLC plates were visualized by exposure to UV light. Silica gel (60 120) column chromatography was performed by using indicated solvent system. 1 H and 13 C NMR spectra were recorded relative to tertramethylsilane (TMS) and chemical shifts were reported in parts per million (δ). Melting points were recorded on an Electrothermal melting apparatus and are uncorrected. HRMS were performed on an ESI-QTOF mass spectrometer. X-ray Crystallography: 3-Hydroxy-4-(4-methoxyphenyl)-1-methylquinolin-2(1H)-one (4j) (CCDC: 1832714) O OH N O Figure S1. X-Ray crystal structure of 4j, showing the atom-labeling scheme. Displacement ellipsoids are drawn at the 30% probability level and H atoms are represented by circles of arbitrary radii. 2

X-ray data for the compound 4j was collected at room temperature on a Bruker D8 QUEST instrument with an IµS Mo microsource (λ = 0.7107 A) and a PHOTON-100 detector. The raw data frames were reduced and corrected for absorption effects using the Bruker Apex 3 software suite programs. 1 The structure was solved using intrinsic phasing method 2 and further refined with the SHELXL 2 program and expanded using Fourier techniques. Anisotropic displacement parameters were included for all non-hydrogen atoms. O bound H atom was located in difference Fourier maps and their positions and isotropic displacement parameters were refined. All other C bound H atoms were positioned geometrically and treated as riding on their parent C atoms [C-H = 0.93-0.97 Å, and U iso (H) = 1.5U eq (C) for methyl H or 1.2U eq (C) for other H atoms]. Crystal Data for KA244: C 17 H 15 NO 3 (M =281.31 g/mol): monoclinic, space group P2 1 /n (no. 14), a = 6.0088(1) Å, b = 21.3777(5) Å, c = 10.8832(2) Å, β = 93.6225(7), V = 1395.20(5) Å 3, Z = 4, T = 294.15 K, µ(mo Kα) = 0.092 mm -1, Dcalc = 1.3391 g/cm 3, 50265 reflections measured (5.34 2Θ 61.42 ), 4330 unique (R int = 0.0856, R sigma = 0.0516) which were used in all calculations. The final R 1 was 0.0686 (I>2σ(I)) and wr 2 was 0.1577 (all data). CCDC 1832714 contains supplementary Crystallographic data for the structure. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre (CCDC), 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(0) 1223 336 033; email: deposit@ccdc.cam.ac.uk]. References: 1. Bruker (2016). APEX3, SAINT and SADABS. Bruker AXS, Inc., Madison, Wisconsin, USA. 2. Sheldrick, G. M. Acta Cryst. 2015, C71, 3-8. 3

General procedure for the synthesis of 4 and 5: A mixture of aldehydes (2, 1 mmol) and p- toluenesulfonyl hydrazide (3, 1 mmol) in ethanol was stirred at room temperature until complete consumption of starting materials (monitored by TLC). Then, isatins (1, 1 mmol) and K 2 CO 3 (2 mmol) was added to the reaction mixture and stirred at 80 o C for 8 h. After the reaction was finished, the solvent was removed under reduced pressure and the residue was purified by silica gel column chromatography (Petroleum ether/ethyl acetate) to afford the desired products 4 and 5. 3-Hydroxy-4-phenylquinolin-2(1H)-one (4a or II): By following the general procedure, 4a was purified by silica gel chromatography (EA/PE = 20/80). White solid; Yield: 203 mg (86%); mp: 267 269 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.17 (s, 1H), 9.16 (s, 1H), 7.45 (t, J = 7.2 Hz, 2H), 7.37 (t, J = 7.3 Hz, 1H), 7.28 (t, m, 4H), 7.05 6.96 (m, 2H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.7, 142.9, 134.2, 133.6, 130.3, 128.8, 128.1, 126.9, 124.7, 124.4, 122.6, 121.4, 115.7; MS (ESI): m/z 238 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 12 O 2 N: 238.0863; found: 238.0857 [M + H] +. 3-Hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (4b): By following the general procedure, 4b was purified by silica gel chromatography (EA/PE = 30/70). White solid; Yield: 248 mg (93%); mp: 242 244 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.19 (s, 1H), 9.11 (s, 1H), 7.31 (dt, J = 16.3, 7.4 Hz, 4H), 7.10 (dt, J = 13.3, 8.2 Hz, 4H), 3.83 (s, 3H); 13 C NMR (101 MHz, DMSO d 6 ) δ 159.1, 158.7, 142.9, 133.6, 131.6, 126.8, 126.0, 124.9, 124.2, 122.5, 121.6, 115.7, 114.2, 55.6; MS (ESI): m/z 268 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 3 N: 268.0968; found: 268.0963 [M + H] +. 4

3-Hydroxy-4-(3-methoxyphenyl)quinolin-2(1H)-one (4c): By following the general procedure, 4c was purified by silica gel chromatography (EA/PE = 30/70). Off white solid; Yield: 245 mg (92%); mp: 260 262 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.22 (s, 1H), 9.21 (s, 1H), 7.43 (t, J = 7.9 Hz, 1H), 7.33 (bs, 2H), 7.07 (s, 2H), 7.01 (d, J = 7.4 Hz, 1H), 6.88 (d, J = 7.2 Hz, 2H), 3.78 (s, 3H); 13 C NMR (101 MHz, DMSO d 6 ) δ 159.7, 158.7, 142.8, 135.6, 133.6, 129.9, 126.9, 124.8, 124.3, 122.6, 122.5, 121.3, 115.9, 115.7, 113.6, 55.5; MS (ESI): m/z 268 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 3 N: 268.0968; found: 268.0975 [M + H] +. 3-Hydroxy-4-(2-methoxyphenyl)quinolin-2(1H)-one (4d): By following the general procedure, 4d was purified by silica gel chromatography (EA/PE = 35/65). White solid; Yield: 235 mg (88%); mp: 254 256 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.17 (s, 1H), 9.09 (s, 1H), 7.47 7.40 (m, 1H), 7.29 (q, J = 7.9 Hz, 2H), 7.19 7.12 (m, 2H), 7.09 7.00 (m, 2H), 6.83 (d, J = 7.9 Hz, 1H), 3.65 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.3, 156.6, 142.8, 132.9, 131.0, 129.4, 126.1, 124.3, 122.3, 121.97, 121.4, 121.0, 120.4, 115.0, 111.4, 55.2; MS (ESI): m/z 268 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 3 N: 268.0968; found: 268.0974 [M + H] +. 4-(4-Chlorophenyl)-3-hydroxyquinolin-2(1H)-one (4e): 5

By following the general procedure, 4e was purified by silica gel chromatography (EA/PE = 25/75). Off white solid; Yield: 227 mg (84%); mp: 266 268 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.23 (s, 1H), 9.20 (s, 1H), 7.52 (dd, J = 10.1, 4.5 Hz, 2H), 7.47 7.42 (m, 1H), 7.37 7.29 (m, 3H), 7.12 7.04 (m, 2H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.1, 142.6, 133.1, 132.5, 132.4, 131.8, 128.4, 126.5, 124.0, 122.6, 122.2, 120.5, 115.3; MS (ESI): m/z 272 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 11 O 2 NCl: 272.0473; found: 272.0467 [M + H] +. 3-Hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (4f): By following the general procedure, 4f was purified by silica gel chromatography (EA/PE = 35/65). Pale yellow solid; Yield: 223 mg (79%); mp: 285 287 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.32 (s, 1H), 9.67 (s, 1H), 8.37 (d, J = 8.7 Hz, 2H), 7.66 (d, J = 8.7 Hz, 2H), 7.42 7.27 (m, 2H), 7.10 (ddd, J = 8.1, 5.3, 2.9 Hz, 1H), 7.01 (d, J = 8.0 Hz, 1H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.4, 147.4, 143.3, 141.5, 133.6, 132.0, 127.2, 124.3, 124.0, 122.8, 122.4, 120.4, 115.9; MS (ESI): m/z 283 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 11 O 4 N 2 : 283.0713; found: 283.0707 [M + H] +. 4-(2-Ethoxyphenyl)-3-hydroxyquinolin-2(1H)-one (4g): By following the general procedure, 4gwas purified by silica gel chromatography (EA/PE = 30/70). Off white solid; Yield: 239 mg (85%); mp: 193 195 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.17 (s, 1H), 9.06 (s, 1H), 7.45 7.37 (m, 1H), 7.30 (d, J = 6.3 Hz, 2H), 7.19 7.12 (m, 2H), 7.04 (td, J = 7.8, 4.0 Hz, 2H), 6.88 (d, J = 8.0 Hz, 1H), 3.98 (qd, J = 6.9, 2.4 Hz, 2H), 1.04 (t, J = 6.9 Hz, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.3, 155.9, 142.7, 132.8, 131.3, 129.3, 126.1, 124.4, 122.7, 121.8, 121.6, 121.0, 120.3, 115.0, 112.7, 63.3, 14.4; MS (ESI): m/z 282 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 16 O 3 N: 282.1130; found: 282.1131 [M + H] +. 6

4-(2-Bromophenyl)-3-hydroxyquinolin-2(1H)-one (4h): By following the general procedure, 4h was purified by silica gel chromatography (EA/PE = 25/75). Off white solid; Yield: 245 mg (78%); mp: 302 304 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.28 (s, 1H), 9.48 (s, 1H), 7.80 (dd, J = 8.0, 0.9 Hz, 1H), 7.52 (td, J = 7.4, 1.1 Hz, 1H), 7.41 (td, J = 7.7, 1.7 Hz, 1H), 7.37 7.29 (m, 3H), 7.07 (ddd, J = 8.2, 6.3, 2.1 Hz, 1H), 6.74 (d, J = 7.9 Hz, 1H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.2, 142.8, 135.0, 133.0, 132.5, 131.7, 129.9, 127.9, 126.4, 123.8, 123.4, 123.2, 122.2, 120.3, 115.2; MS (ESI): m/z 315 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 11 O 2 NBr: 315.9968; found: 315.9978 [M + H] +. 3-Hydroxy-1-methyl-4-phenylquinolin-2(1H)-one (4i): By following the general procedure, 4iwas purified by silica gel chromatography (EA/PE = 10/90). White solid; Yield: 226 mg (90%); mp: 212 214 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 9.23 (s, 1H), 7.57 (d, J = 8.5 Hz, 1H), 7.55 7.49 (m, 2H), 7.49 7.42 (m, 2H), 7.35 7.30 (m, 2H), 7.21 7.09 (m, 2H), 3.79 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.0, 141.6, 134.2, 133.6, 129.8, 128.3, 127.7, 126.8, 124.9, 122.9, 122.4, 121.3, 114.7, 29.9; MS (ESI): m/z 252 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 2 N: 252.1019; found: 252.1013 [M + H] +. 3-Hydroxy-4-(4-methoxyphenyl)-1-methylquinolin-2(1H)-one (4j): By following the general procedure, 4j was purified by silica gel chromatography (EA/PE = 15/85). White solid; Yield: 270 mg (96%); mp: 223 225 o C; 1 H NMR (400 MHz, CDCl 3 ) δ 7.49 7

7.40 (m, 3H), 7.38 7.34 (m, 2H), 7.20 (ddd, J = 8.2, 6.8, 1.5 Hz, 1H), 7.13 (s, 1H), 7.09 7.04 (m, 2H), 3.89 (s, 6H); 13 C NMR (101 MHz, CDCl 3 ) δ 159.4, 159.0, 140.9, 134.4, 131.1, 127.2, 126.2, 124.9, 123.0, 122.9, 122.3, 114.1, 114.0, 55.3, 30.4;MS (ESI): m/z 282 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 16 O 3 N: 282.1125; found: 282.1116 [M + H] +. 4-(4-Chlorophenyl)-3-hydroxy-1-methylquinolin-2(1H)-one (4k): By following the general procedure, 4k was purified by silica gel chromatography (EA/PE = 15/85). Off white solid; Yield: 248 mg (87%) mp: 244 246 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 9.37 (s, 1H), 7.59 (dt, J = 4.3, 2.4 Hz, 3H), 7.47 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.40 7.35 (m, 2H), 7.22 7.15 (m, 1H), 7.12 (dd, J = 8.0, 1.4 Hz, 1H), 3.79 (s, 3H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.4, 142.3, 134.8, 133.0, 132.9, 132.3, 128.9, 127.4, 125.2, 123.1, 122.2, 121.5, 115.3, 30.5; MS (ESI): m/z 286 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 2 NCl: 286.0629; found: 286.0622 [M + H] +. NO 2 OH N O 3-Hydroxy-1-methyl-4-(4-nitrophenyl)quinolin-2(1H)-one (4l): By following the general procedure, 4l was purified by silica gel chromatography (EA/PE = 25/75). Pale yellow solid; Yield: 245 mg (83%); mp: 276 278 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 9.71 (s, 1H), 8.43 (d, J = 8.6 Hz, 2H), 7.69 (d, J = 8.6 Hz, 2H), 7.65 (d, J = 8.7 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.25 (t, J = 7.5 Hz, 1H), 7.12 (d, J = 7.8 Hz, 1H), 3.84 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 157.7, 146.9, 141.8, 140.9, 134.2, 131.5, 127.2, 124.4, 123.5, 122.8, 121.0, 120.4, 114.9, 30.0; MS (ESI): m/z 297 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 4 N 2 : 297.0870 found: 297.0862 [M + H] +. 8

4-(2-Bromophenyl)-3-hydroxy-1-methylquinolin-2(1H)-one (4m) By following the general procedure, 4m was purified by silica gel chromatography (EA/PE = 20/80). Off white solid; Yield: 260 mg (79%); mp: 238 240 o C; 1 H NMR (500 MHz, CDCl 3 ) δ 7.77 (dd, J = 8.0, 1.0 Hz, 1H), 7.50 7.42 (m, 3H), 7.37 7.29 (m, 2H), 7.19 (ddd, J = 8.1, 6.9, 1.4 Hz, 1H), 7.15 (s, 1H), 7.08 (dd, J = 8.0, 1.2 Hz, 1H), 3.91 (s, 3H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.5, 142.5, 135.4, 134.6, 133.0, 132.2, 130.5, 128.5, 127.4, 124.9, 124.0, 123.2, 122.8, 121.2, 115.3, 30.5; MS (ESI): m/z 330 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 2 NBr: 330.0124; found: 330.0135 [M + H] +. 1-Benzyl-3-hydroxy-4-phenylquinolin-2(1H)-one (4n): By following the general procedure, 4n was purified by silica gel chromatography (EA/PE = 15/85). White solid; Yield: 291 mg (89%); mp: 243 245 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 9.41 (s, 1H), 7.54 (t, J = 7.2 Hz, 2H), 7.45 (dd, J = 11.1, 7.9 Hz, 2H), 7.40 7.31 (m, 5H), 7.28 (d, J = 7.3 Hz, 3H), 7.13 (d, J = 3.5 Hz, 2H), 5.68 (s, 2H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.4, 141.5, 136.54, 133.6, 133.5, 129.9, 128.6, 128.4, 127.7, 127.1, 126.8, 126.5, 125.1, 123.7, 122.5, 121.7, 115.1, 45.6; MS (ESI): m/z 328 [M + H] + ; HRMS (ESI): m/z calcd for C 22 H 18 O 2 N: 328.1332; found: 328.1323 [M + H] +. 9

1-Benzyl-3-hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (4o): By following the general procedure, 4o was purified by silica gel chromatography (EA/PE = 20/80). Off white solid; Yield: 335 mg (94%); mp: 266 268 o C; 1 H NMR (400 MHz, CDCl 3 ) δ 7.47 7.43 (m, 1H), 7.42 7.38 (m, 2H), 7.37 7.31 (m, 4H), 7.28 (dt, J = 4.6, 2.8 Hz, 3H), 7.14 (td, J = 6.7, 1.9 Hz, 2H), 7.11 7.06 (m, 2H), 5.69 (s, 2H), 3.89 (s, 3H); 13 C NMR (101 MHz, CDCl 3 ) δ 159.5, 159.4, 140.8, 135.8, 133.9, 131.2, 128.9, 127.5, 127.3, 126.6, 126.4, 124.9, 123.7, 123.0, 122.5, 115.1, 114.1, 55.3, 47.1; MS (ESI): m/z 357 [M + H] + ; HRMS (ESI): m/z calcd for C 23 H 20 O 3 N: 358.1438; found: 358.1432 [M + H] +. 1-Benzyl-4-(4-chlorophenyl)-3-hydroxyquinolin-2(1H)-one (4p): By following the general procedure, 4p was purified by silica gel chromatography (EA/PE = 20/80). White solid; Yield: 310 mg (86%); mp: 215 217 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 9.50 (s, 1H), 7.54 (d, J = 7.5 Hz, 2H), 7.42 7.15 (m, 9H), 7.06 (s, 2H), 5.61 (s, 2H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.8, 142.3, 136.9, 134.0, 133.0, 133.0, 132.4, 129.2, 129.0, 127.6, 127.4, 127.0, 125.5, 123.2, 123.0, 121.9, 115.7, 46.1; MS (ESI): m/z 362 [M + H] + ; HRMS (ESI): m/z calcd for C 22 H 17 O 2 NCl: 362.0942; found: 362.0937 [M + H] +. 1-Benzyl-3-hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (4q): By following the general procedure, 4q was purified by silica gel chromatography (EA/PE = 30/70). Off white solid, Yield: 297 mg (80%); mp: 258 260 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 9.69 (s, 1H), 8.39 (d, J = 7.9 Hz, 2H), 7.69 (d, J = 7.8 Hz, 2H), 7.43 (d, J = 8.1 Hz, 1H), 7.38 10

7.22 (m, 6H), 7.12 (d, J = 3.6 Hz, 2H), 5.69 (s, 2H); 13 C NMR (75 MHz, DMSO d 6 + CDCl 3 ) δ 158.2, 146.9, 141.9, 140.9, 136.3, 133.5, 131.5, 128.6, 127.1, 126.9, 126.53, 124.7, 123.4, 122.7, 121.6, 120.8, 115.3, 45.7; MS (ESI): m/z 373 [M + H] + ; HRMS (ESI): m/z calcd for C 22 H 17 O 4 N 2 : 373.1183; found: 373.1180 [M + H] +. OH 3-Hydroxy-4-(3-hydroxyphenyl)quinolin-2(1H)-one or Viridicatol (4r or III): N H By following the general procedure, IV was purified by silica gel chromatography (EA/PE = 35/65). White solid; Yield: 184 mg (73%); mp: 238 240 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.22 (s, 1H), 9.54 (s, 1H), 9.18 (s, 1H), 7.41 7.22 (m, 3H), 7.09 (s, 2H), 6.82 (d, J = 7.4 Hz, 1H), 6.72 (d, J = 6.5 Hz, 2H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.2, 157.2, 142.1, 134.8, 133.0, 129.3, 126.3, 124.4, 124.0, 122.0, 120.8, 120.3, 116.6, 115.18, 114.5; MS (ESI): m/z 284 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 4 N: 254.0812; found: 254.0820 [M + H] +. N OH O OH 3-Hydroxy-4-(pyridin-4-yl)quinolin-2(1H)-one (4s): N H By following the general procedure, 4s was purified by silica gel chromatography (MeOH/EA = 5/95). Off white solid, Yield: 190 mg (80%); mp: 390 392 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.30 (s, 1H), 9.59 (s, 1H), 8.72 (d, J = 5.8 Hz, 2H), 7.39 (d, J = 5.9 Hz, 2H), 7.37 (d, J = 2.7 Hz, 2H), 7.11 (ddd, J = 8.2, 5.4, 2.9 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H); 13 C NMR (75 MHz, DMSO d 6 ) δ 157.9, 149.7, 142.6, 141.9, 133.1, 126.7, 125.0, 123.7, 122.4, 121.3, 119.7, 115.4; MS (ESI): m/z 239 [M + H] + ; HRMS (ESI): m/z calcd for C 14 H 11 O 2 N 2 : 239.0815; found: 239.0813 [M + H] +. O 11

3-Hydroxy-4-(thiophen-2-yl)quinolin-2(1H)-one (4t): By following the general procedure, 4t was purified by silica gel chromatography (EA/PE = 30/70). Off white solid, Yield: 211 mg (87%); mp: 256 258 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.27 (s, 1H), 9.67 (s, 1H), 7.76 (dd, J = 5.1, 1.1 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 3.7 Hz, 2H), 7.24 (dd, J = 5.1, 3.5 Hz, 1H), 7.20 (dd, J = 3.5, 1.1 Hz, 1H), 7.17 7.12 (m, 1H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.2, 144.3, 133.7, 133.4, 129.3, 127.6, 127.5, 127.1, 124.7, 122.8, 121.2, 117.1, 115.8; MS (ESI): m/z 244 [M + H] + ; HRMS (ESI): m/z calcd for C 13 H 10 O 2 NS: 244.0427; found: 244.0435 [M + H] +. 3-Hydroxy-6-methoxy-4-phenylquinolin-2(1H)-one (5a): By following the general procedure, 5a was purified by silica gel chromatography (EA/PE = 30/70). White solid; Yield: 235 mg (88%); mp: 222 224 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.13 (s, 1H), 9.20 (s, 1H), 7.52 (t, J = 7.2 Hz, 2H), 7.44 (t, J = 7.3 Hz, 1H), 7.38 7.32 (m, 2H), 7.29 (d, J = 8.9 Hz, 1H), 7.01 (dd, J = 8.9, 2.7 Hz, 1H), 6.51 (d, J = 2.7 Hz, 1H), 3.59 (s, 3H). 13 C NMR (75 MHz, DMSO d 6 ) δ 157.7, 154.4, 142.9, 133.7, 129.7, 128.3, 127.6, 127.5, 123.4, 121.7, 116.4, 114.3, 107.2, 55.1; MS (ESI): m/z 268 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 14 O 3 N: 268.0968; found: 268.0963 [M + H] +. 3-Hydroxy-6-methoxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (5b): By following the general procedure, 58 was purified by silica gel chromatography (EA/PE = 35/65). Off white solid, Yield: 282 mg (95%) mp: 243 245 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.09 (s, 1H), 9.10 (s, 1H), 7.28 (d, J = 8.0 Hz, 3H), 7.07 (d, J = 8.5 Hz, 2H), 7.00 (d, J = 8.8 Hz, 2H), 6.59 (s, 1H), 3.82 (s, 3H), 3.61 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.6, 157.7, 154.4, 142.9, 131.0, 127.5, 125.5, 123.1, 121.9, 116.4, 114.3, 113.7, 107.3, 55.1, 55.0; MS (ESI): 12

m/z 298 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 16 O 4 N: 298.1074; found: 298.1067 [M + H] +. 4-(4-Chlorophenyl)-3-hydroxy-6-methoxyquinolin-2(1H)-one (5c): By following the general procedure, 5c was purified by silica gel chromatography (EA/PE = 30/70). White solid; Yield: 262 mg (87%); mp: 258 260 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.16 (s, 1H), 9.39 (s, 1H), 7.58 (d, J = 8.4 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.9 Hz, 1H), 7.01 (dd, J = 8.9, 2.7 Hz, 1H), 6.49 (d, J = 2.6 Hz, 1H), 3.61 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 157.5, 154.5, 143.1, 132.5, 132.4, 131.7, 128.4, 127.5, 122.2, 121.3, 116.5, 114.5, 106.8, 55.1; MS (ESI): m/z 302 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 3 NCl: 302.0576; found: 302.0571 [M + H] +. NO 2 O OH 3-Hydroxy-6-methoxy-4-(4-nitrophenyl)quinolin-2(1H)-one (5d): By following the general procedure, 5d was purified by silica gel chromatography (EA/PE = 40/60). Yellow solid; Yield: 249 mg (80%); mp: 319 321 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.16 (s, 1H), 9.61 (s, 1H), 8.31 (d, J = 8.2 Hz, 2H), 7.61 (d, J = 8.1 Hz, 2H), 7.25 (d, J = 8.6 Hz, 1H), 6.97 (d, J = 7.7 Hz, 1H), 6.39 (s, 1H), 3.54 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 157.3, 154.6, 146.9, 143.3, 141.0, 131.4, 127.5, 123.5, 121.4, 120.72, 116.6, 114.7, 106.6, 55.2; MS (ESI): m/z 313 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 5 N 2 : 313.0819; found: 313.0812 [M + H] +. N H O 13

6-Chloro-3-hydroxy-4-phenylquinolin-2(1H)-one (5e): By following the general procedure, 5e was purified by silica gel chromatography (EA/PE = 30/70). White solid; Yield: 230 mg (85%); mp: 257 259; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.38 (s, 1H), 9.55 (s, 1H), 7.54 (t, J = 7.2 Hz, 2H), 7.47 (d, J = 7.1 Hz, 1H), 7.35 (dd, J = 6.3, 4.8 Hz, 4H), 6.94 (s, 1H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.0, 143.5, 133.0, 131.8, 129.7, 128.5, 127.9, 126.2, 126.1, 122.9, 122.8, 122.4, 117.1; MS (ESI): m/z 272 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 11 O 2 NCl: 272.0478; found: 272.0467 [M + H] +. 6-Chloro-3-hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (5f): By following the general procedure, 5f was purified by silica gel chromatography (EA/PE = 35/65). White solid; Yield: 271 mg (90%) mp: 296 298 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.28 (s, 1H), 9.39 (s, 1H), 7.34 7.25 (m, 2H), 7.21 (d, J = 8.6 Hz, 2H), 7.02 (d, J = 8.6 Hz, 2H), 6.96 (s, 1H), 3.77 (s, 3H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.8, 158.0, 143.5, 131.8, 131.0, 126.1, 124.9, 123.1, 122.7, 122.7, 117.1, 113.9, 55.0; MS (ESI): m/z 302 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 3 NCl: 302.0579; found: 302.0573 [M + H] +. 6-Chloro-4-(4-chlorophenyl)-3-hydroxyquinolin-2(1H)-one (5g) By following the general procedure, 5g was purified by silica gel chromatography (EA/PE = 35/65). Off white solid; Yield: 244 mg (80%); mp: 322 324 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.34 (s, 1H), 9.65 (s, 1H), 7.53 (d, J = 8.4 Hz, 2H), 7.31 (dd, J = 10.3, 6.1 Hz, 4H), 6.87 (d, J = 1.6 Hz, 1H); 13 C NMR (75 MHz, DMSO d 6 ) δ 157.9, 143.7, 132.7, 131.9, 131.8, 131.7, 128.6, 126.3, 122.7, 122.1, 121.6, 117.1; MS (ESI): m/z 306 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 10 O 2 NCl 2 : 306.0083; found: 306.0077 [M + H] +. 14

6-Chloro-3-hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (5h): By following the general procedure, 5h was purified by silica gel chromatography (EA/PE = 45/55). Pale yellow solid; Yield: 246 mg (78%); mp: 323 324 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.46 (s, 1H), 9.97 (s, 1H), 8.38 (d, J = 8.7 Hz, 2H), 7.66 (d, J = 8.6 Hz, 2H), 7.44 7.35 (m, 2H), 6.92 (s, 1H); 13 C NMR (101 MHz, DMSO d 6 ) δ 158.2, 147.6, 144.4, 140.8, 132.4, 131.9, 127.0, 126.9, 124.2, 123.1, 122.0, 121.4, 117.7; MS (ESI): m/z 317 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 9 O 4 N 2 Cl: 317.0329; found: 317.2420 [M + H] +. 3-Hydroxy-6-nitro-4-phenylquinolin-2(1H)-one (5i): By following the general procedure, 5i was purified by silica gel chromatography (EA/PE = 35/65). Yellow solid; Yield: 216 mg (77%); mp: 333 335 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.80 (s, 1H), 9.88 (s, 1H), 8.19 (dd, J = 9.0, 2.5 Hz, 1H), 7.90 (d, J = 2.5 Hz, 1H), 7.58 (t, J = 7.3 Hz, 2H), 7.51 (dt, J = 7.3, 2.7 Hz, 2H), 7.43 7.38 (m, 2H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.5, 144.0, 141.9, 137.7, 132.6, 129.8, 128.6, 128.2, 123.4, 121.2, 121.0, 120.0, 116.2; MS (ESI): m/z 283 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 11 O 4 N 2 : 283.0713; found: 283.0706 [M + H] +. 3-Hydroxy-4-(4-methoxyphenyl)-6-nitroquinolin-2(1H)-one (5j): By following the general procedure, 5j was purified by silica gel chromatography (EA/PE = 40/60). Yellow solid; Yield: 259 mg (83%); mp: 250 252 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 15

12.78 (s, 1H), 9.81 (s, 1H), 8.18 (d, J = 9.0 Hz, 1H), 7.97 (s, 1H), 7.49 (d, J = 8.9 Hz, 1H), 7.33 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 8.4 Hz, 2H), 3.85 (s, 3H); 13 C NMR (101 MHz, DMSO d 6 ) δ 159.5, 159.0, 144.6, 142.4, 138.2, 131.6, 124.9, 123.8, 121.8, 120.7, 116.7, 114.5, 55.6; MS (ESI): m/z 313 [M + H] + ; HRMS (ESI): m/z calcd for C 16 H 13 O 5 N 2 : 313.0819; found: 313.0812 [M + H] +. 4-(4-Chlorophenyl)-3-hydroxy-6-nitroquinolin-2(1H)-one (5k) By following the general procedure, 5k was purified by silica gel chromatography (EA/PE = 45/55). Yellow solid; Yield: 253 mg (80%); mp: 374 376 o C; 1 H NMR (300 MHz, DMSO d 6 ) δ 12.82 (s, 1H), 10.05 (s, 1H), 8.19 (dd, J = 9.0, 2.4 Hz, 1H), 7.86 (d, J = 2.3 Hz, 1H), 7.64 (d, J = 8.4 Hz, 2H), 7.50 (d, J = 9.0 Hz, 1H), 7.44 (d, J = 8.4 Hz, 2H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.3, 144.3, 141.9, 137.7, 133.0, 131.8, 131.4, 128.7, 122.2, 121.3, 120.6, 119.7, 116.2; MS (ESI): m/z 317 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 10 O 4 N 2 Cl: 317.0324; found: 317.0315[M + H] +. 3-Hydroxy-6-nitro-4-(4-nitrophenyl)quinolin-2(1H)-one (5l): By following the general procedure, 5l was purified by silica gel chromatography (EA/PE = 55/45). Yellow solid; Yield: 235 mg (72%); mp: 380 382 o C; 1 H NMR (400 MHz, DMSO d 6 ) δ 12.88 (s, 1H), 10.31 (s, 1H), 8.42 (d, J = 7.6 Hz, 2H), 8.22 (d, J = 8.9 Hz, 1H), 7.83 (s, 1H), 7.73 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 8.9 Hz, 1H); 13 C NMR (75 MHz, DMSO d 6 ) δ 158.2, 147.2, 144.5, 142.0, 139.7, 137.7, 131.5, 123.8, 121.5, 121.4, 120.1, 119.5, 116.3; MS (ESI): m/z 328 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 10 O 6 N 3 : 328.0570; found: 328.0554 [M + H] +. 16

4-(4-Chlorophenyl)-8-fluoro-3-hydroxyquinolin-2(1H)-one (5m): The compound 5m was prepared by following the general procedure by taking 4- chlorobenzaldehyde (30 mg, 0.21 mmol), p-toluenesulfonyl hydrazide (39 mg, 0.21 mmol), 7- fluoroisatin (35 mg, 0.21 mmol) and K 2 CO 3 (59 mg, 0.42 mmol) and purified by silica gel chromatography (EA/PE = 25/75). White solid; Yield: 50 mg (81%); mp: 282 284 o C; 1 H NMR (500 MHz, DMSO d 6 ) δ 12.28 (s, 1H), 9.65 (s, 1H), 7.58 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.25 (dd, J = 10.2, 8.3 Hz, 1H), 7.07 (td, J = 8.1, 5.3 Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H); 13 C NMR (126 MHz, DMSO d 6 ) δ 158.5, 149.7 (d, J = 245.0 Hz), 133.0, 132.8, 132.2, 128.9, 123.4 (d, J = 3.0 Hz), 122.8 (d, J = 2.6 Hz), 122.5 (d, J = 7.4 Hz), 122.1 (d, J = 13.9 Hz), 120.3 (d, J = 3.1 Hz); MS (ESI): m/z 290 [M + H] + ; HRMS (ESI): m/z calcd for C 14 H 10 O 2 N 2 FCl: 290.0384; found: 290.0375 [M + H] +. 3-Hydroxy-6,8-dimethyl-4-phenylquinolin-2(1H)-one (5n): The compound 5n was prepared by following the general procedure by taking benzaldehyde (30 mg, 0.28 mmol), p-toluenesulfonyl hydrazide (52 mg, 0.28 mmol), 5,7-dimethylisatin (49 mg, 0.28 mmol) and K 2 CO 3 (78 mg, 0.56 mmol) and purified by silica gel chromatography (EA/PE = 20/80). White solid; Yield: 62 mg (83%); mp: 242 244 o C; 1 H NMR (500 MHz, DMSO d 6 ) δ 11.30 (s, 1H), 9.11 (s, 1H), 7.48 (dd, J = 31.0, 6.6 Hz, 3H), 7.31 (d, J = 6.3 Hz, 2H), 7.02 (s, 1H), 6.68 (s, 1H), 2.45 (s, 3H), 2.17 (s, 3H); 13 C NMR (126 MHz, DMSO d 6 ) δ 159.0, 142.6, 134.6, 131.0, 130.2, 130.0, 129.8, 128.7, 128.0, 124.7, 123.8, 122.6, 121.5, 21.0, 17.9; MS (ESI): m/z 266 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 16 O 2 N: 266.1181; found: 266.1184 [M + H] +. 17

4-(4-Chlorophenyl)-3-hydroxy-6,8-dimethylquinolin-2(1H)-one (5o): The compound 5o was prepared by following the general procedure by taking 4- chlorobenzaldehyde (30 mg, 0.21 mmol), p-toluenesulfonyl hydrazide (39 mg, 0.21 mmol), 5,7- dimethylisatin (37 mg, 0.21 mmol) and K 2 CO 3 (59 mg, 0.42 mmol) purified by silica gel chromatography (EA/PE = 25/75). White solid; Yield: 50 mg (79%); mp: 267 269 o C; 1 H NMR (500 MHz, DMSO d 6 ) δ 11.32 (s, 1H), 9.28 (s, 1H), 7.57 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H), 7.03 (s, 1H), 6.67 (s, 1H), 2.44 (s, 3H), 2.18 (s, 3H); 13 C NMR (126 MHz, DMSO d 6 ) δ 158.8, 142.8, 133.5, 132.8, 132.2, 131.2, 130.0, 129.9, 128.9, 123.9, 123.5, 122.4, 121.1, 21.0, 17.8; MS (ESI): m/z 300 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 15 O 2 NCl: 300.0791; found: 300.0782 [M + H] +. 5,6-Dichloro-3-hydroxy-4-phenylquinolin-2(1H)-one (5p): The compound 5p was prepared by following the general procedure by taking benzaldehyde (30 mg, 0.28 mmol), p-toluenesulfonyl hydrazide (52 mg, 0.28 mmol), 4,5-dichlorolisatin (61 mg, 0.28 mmol) and K 2 CO 3 (78 mg, 0.56 mmol) and purified by silica gel chromatography (EA/PE = 35/65). Off white solid; Yield: 60 mg (70%); mp: 278 280 o C; 1 H NMR (500 MHz, DMSO d 6 ) δ 12.56 (s, 1H), 9.63 (s, 1H), 7.57 (d, J = 8.7 Hz, 1H), 7.45 7.33 (m, 4H), 7.22 (d, J = 6.8 Hz, 2H); 13 C NMR (126 MHz, DMSO d 6 ) δ 157.5, 146.3, 136.5, 134.0, 130.0, 128.1, 127.8, 127.7, 127.6, 127.1, 123.6, 119.8, 116.4; MS (ESI): m/z 306 [M + H] + ; HRMS (ESI): m/z calcd for C 15 H 10 O 2 NCl 2 : 306.0089; found: 306.0093 [M + H] +. 18

3-Methoxy-1-methyl-4-phenylquinolin-2(1H)-one (6): To a stirred solution of viridicatin (4a, 110 mg, 0.42 mmol) in THF:H 2 O (1:1) was added NaOH (34 mg, 0.84 mmol) and dimethyl sulfate (106 mg, 0.84 mmol), the resulting mixture was stirred at room temperature for 12 h. After completion of the reaction monitored by TLC, the reaction mixture was concentrated under reduced pressure and diluted with water, extracted with DCM. The organic layer was washed with brine, dried over anhydrous Na 2 SO 4, and evaporated to afford crude product. The residue was purified by silica gel chromatography (EA/PE = 30/70). White solid; Yield: 107 mg (96%); mp: 197 199 o C; Mp: 200 203 o C; 1 H NMR (400 MHz, CDCl 3 ) δ 7.54 7.43 (m, 1H), 7.42 7.37 (m, 1H), 7.35 7.30 (m, 1H), 7.24 (dd, J = 8.1, 1.4 Hz, 1H), 7.13 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 3.83 (s, 1H), 3.76 (s, 1H); 13 C NMR (101 MHz, CDCl 3 ) δ 159.3, 145.1, 137.3, 137.1, 133.5, 129.5, 128.9, 128.4, 128.1, 127.4, 122.3, 121.3, 114.0, 60.2, 29.9; MS (ESI): m/z 266 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 16 O 2 N: 266.1176; found: 266.1180 [M + H] +. 2-Oxo-4-phenyl-1,2-dihydroquinolin-3-yl acetate (7): To mixture of viridicatin (4a, 100 mg 0.42 mmol) and Et 3 N (87 µl, 0.63 mmol) in DCM, acetyl chloride (30 µl, 0.42 mmol) was added at 0 o C. Then the reaction mixture was allowed to stir at room temperature for 4 h. After completion of the reaction monitored by TLC, the reaction mixture was diluted with water and extracted with DCM. The organic layer was washed with brine, dried over anhydrous Na 2 SO 4, and evaporated to afford the crude product, which was purified by silica gel chromatography (EA/PE = 25/75). White solid; Yield: 109 mg (93%); mp: 188 190 o C; 1 H NMR (400 MHz, CDCl 3 ) δ 11.99 (s, 1H), 7.54 7.47 (m, 4H), 7.44 (d, J = 8.0 Hz, 1H), 7.36 7.32 (m, 2H), 7.29 7.25 (m, 1H), 7.15 (t, J = 7.5 Hz, 1H), 2.17 (s, 3H); 13 C NMR (101 MHz, CDCl 3 ) δ 168.9, 159.0, 141.9, 137.3, 136.5, 132.3, 130.1, 128.9, 128.7, 128.5, 126.8, 122.9, 120.0, 116.4, 20.4; 19

MS (ESI): m/z 280 [M + H] + ; HRMS (ESI): m/z calcd for C 17 H 14 O 3 N: 280.0968; found: 280.0974 [M + H] +. (E)-N'-Benzylidene-4-methylbenzenesulfonohydrazide (8): A mixture of benzaldehyde (106 mg, 1 mmol) and p-toluenesulfonyl hydrazide (186 mg, 1 mmol) in ethanol was stirred at room temperature for 1 h. After the reaction was finished monitored by TLC, the solvent was evaporated under reduced pressure and dried in vacuum to afford the desired product as White solid; Yield: 264 mg (96%); mp: 72-74 o C; 1 H NMR (400 MHz, CDCl 3 ) δ 7.98 (s, 1H), 7.93 7.86 (m, 2H), 7.76 (s, 1H), 7.61 7.56 (m, 2H), 7.36 (ddd, J = 5.5, 3.5, 1.7 Hz, 3H), 7.31 (d, J = 8.0 Hz, 2H), 2.41 (s, 3H); 13 C NMR (101 MHz, CDCl 3 ) δ 148.1, 144.3, 135.2, 133.2, 130.3, 129.7, 128.6, 127.9, 127.4, 21.6; MS (ESI): m/z 275 [M + H] + ; HRMS (ESI): m/z calcd for C 14 H 15 O 2 N 2 S: 275.0849; found: 275.0853 [M + H] +. 20

3-Hydroxy-4-phenylquinolin-2(1H)-one or Viridicatin (4a or II): OH N O H 4a 1 H NMR, 300 MHz 21

3-Hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (4b) 159.17 158.77 142.94 133.64 131.60 126.89 126.07 124.90 124.21 122.59 121.62 115.74 114.29 55.62 0.92 0.96 4.00 4.05 3.00 12.19 12.09 9.11 7.36 7.34 7.33 7.30 7.28 7.26 7.14 7.12 7.10 7.10 7.09 7.06 3.83 22

23 3-Hydroxy-4-(3-methoxyphenyl)quinolin-2(1H)-one (4c): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 3.00 1.98 0.99 2.07 1.92 1.09 0.92 0.90 3.78 6.87 6.89 6.99 7.02 7.07 7.33 7.40 7.43 7.45 9.21 12.22 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 55.59 113.60 115.72 115.95 121.39 122.51 122.63 124.35 124.87 126.91 129.96 133.60 135.63 142.88 158.77 159.72

3-Hydroxy-4-(2-methoxyphenyl)quinolin-2(1H)-one (4d): 24

4-(4-Chlorophenyl)-3-hydroxyquinolin-2(1H)-one (4e): 25

3-Hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (4f): 26

27 4-(2-Ethoxyphenyl)-3-hydroxyquinolin-2(1H)-one (4g): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 3.00 2.08 0.98 1.99 1.98 2.04 1.08 0.93 0.94 1.01 1.04 1.06 3.94 3.95 3.97 3.98 3.99 4.00 4.01 4.02 6.87 6.89 7.01 7.02 7.04 7.05 7.06 7.07 7.14 7.14 7.16 7.29 7.31 7.38 7.39 7.41 7.43 7.44 9.06 12.17 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 14.44 63.35 112.70 115.00 120.39 121.00 121.60 121.81 122.76 124.49 126.10 129.39 131.23 132.86 142.75 155.95 158.36

4-(2-Bromophenyl)-3-hydroxyquinolin-2(1H)-one (4h): 28

3-Hydroxy-1-methyl-4-phenylquinolin-2(1H)-one (4i): 29

3-Hydroxy-4-(4-methoxyphenyl)-1-methylquinolin-2(1H)-one (4j): 30

4-(4-Chlorophenyl)-3-hydroxy-1-methylquinolin-2(1H)-one (4k): 31

32 3-Hydroxy-1-methyl-4-(4-nitrophenyl)quinolin-2(1H)-one (4l): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 f1 (ppm) 3.75 1.00 1.04 0.96 0.96 1.94 2.02 0.92 3.84 7.11 7.13 7.23 7.25 7.28 7.52 7.54 7.57 7.63 7.66 7.68 7.71 8.42 8.45 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 f1 (ppm) 30.08 114.95 120.40 121.08 122.81 123.58 124.47 127.24 131.55 134.29 140.94 141.86 146.97 157.79

4-(2-Bromophenyl)-3-hydroxy-1-methylquinolin-2(1H)-one (4m): 158.54 142.52 134.68 133.07 132.26 130.54 128.50 127.44 124.92 123.22 115.33 30.50 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 33

1-Benzyl-3-hydroxy-4-phenylquinolin-2(1H)-one (4n): 0.94 2.21 2.35 5.23 3.11 2.00 1.92 9.41 7.56 7.54 7.51 7.48 7.46 7.45 7.42 7.39 7.36 7.36 7.35 7.33 7.29 7.26 7.13 7.12 5.68 34

35 1-Benzyl-3-hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (4o): 3.00 1.95 2.09 2.09 3.15 4.13 2.06 1.04 3.89 5.69 7.07 7.07 7.09 7.09 7.14 7.15 7.26 7.27 7.29 7.31 7.32 7.32 7.33 7.34 7.34 7.39 7.40 7.41 7.41 7.44 7.44 7.46 47.13 55.37 114.16 115.11 122.59 123.08 123.75 124.98 126.40 126.67 127.34 127.59 128.96 131.25 133.91 135.80 140.83 159.40 159.56

1-Benzyl-4-(4-chlorophenyl)-3-hydroxyquinolin-2(1H)-one (4p): 36

1-Benzyl-3-hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (4q): 37

3-Hydroxy-4-(3-hydroxyphenyl)quinolin-2(1H)-one or Viridicatol ( 4r or III): 38

39 3-Hydroxy-4-(pyridin-4-yl)quinolin-2(1H)-one (4s): -3-2 -1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 f1 (ppm) 1.07 1.10 2.00 2.16 2.15 0.91 1.00 7.01 7.03 7.09 7.10 7.10 7.11 7.12 7.12 7.13 7.36 7.37 7.39 7.40 8.71 8.73 9.59 12.30 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 115.40 119.72 121.36 122.42 123.78 125.05 126.71 133.16 141.98 142.65 149.75 157.99

40 3-Hydroxy-4-(thiophen-2-yl)quinolin-2(1H)-one (4t): 0.5 1.5 2.5 3.5 4.5 5.5 6.5 7.5 8.5 9.5 11.0 12.5 f1 (ppm) 1.16 1.10 1.04 2.10 1.19 0.95 1.00 0.91 7.12 7.13 7.14 7.15 7.15 7.16 7.20 7.20 7.21 7.21 7.23 7.24 7.25 7.26 7.35 7.36 7.39 7.41 7.75 7.76 7.77 7.77 9.67 12.27 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 f1 (ppm) 115.81 117.14 121.28 122.82 124.71 127.16 127.58 127.66 129.39 133.45 133.71 144.34 158.29

3-Hydroxy-6-methoxy-4-phenylquinolin-2(1H)-one (5a): 41

42 3-Hydroxy-6-methoxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (5b): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 3.00 3.13 0.80 1.24 1.98 2.93 0.89 0.87 3.34 3.61 3.82 6.59 6.99 7.02 7.05 7.08 7.27 7.30 9.10 12.09 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 55.08 55.15 107.31 113.79 114.37 116.45 121.98 123.19 125.56 127.53 131.05 142.93 154.42 157.70 158.65

4-(4-Chlorophenyl)-3-hydroxy-6-methoxyquinolin-2(1H)-one (5c): 157.53 154.50 143.14 132.55 132.42 131.76 128.47 127.50 122.21 121.35 116.57 114.59 106.86 55.16 43

3-Hydroxy-6-methoxy-4-(4-nitrophenyl)quinolin-2(1H)-one (5d): 44

45 6-Chloro-3-hydroxy-4-phenylquinolin-2(1H)-one (5e): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 f1 (ppm) 0.75 3.29 2.23 1.11 2.38 1.00 7.05 7.30 7.32 7.35 7.37 7.42 7.43 7.49 7.50 7.52 7.55 7.57 7.58 11.76 0 10 20 30 40 50 60 70 80 90 110 130 150 170 190 210 f1 (ppm) 117.42 123.06 124.90 125.01 127.65 128.75 128.87 129.09 129.74 130.91 132.10 141.87 159.43

46 6-Chloro-3-hydroxy-4-(4-methoxyphenyl)quinolin-2(1H)-one (5f): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 3.00 1.01 2.08 1.83 2.04 0.93 0.86 3.77 6.96 7.01 7.04 7.20 7.22 7.26 7.29 7.33 9.39 12.28 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 f1 (ppm)

6-Chloro-4-(4-chlorophenyl)-3-hydroxyquinolin-2(1H)-one (5g): 47

48 6-Chloro-3-hydroxy-4-(4-nitrophenyl)quinolin-2(1H)-one (5h) 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 0.97 2.22 2.13 2.08 0.97 1.00 6.92 7.39 7.39 7.40 7.42 7.65 7.68 8.36 8.39 9.97 12.46 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 117.79 121.48 122.09 123.11 124.22 126.96 127.02 131.95 132.41 140.85 144.45 147.61 158.28

49 3-Hydroxy-6-nitro-4-phenylquinolin-2(1H)-one (5i): 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.5 12.0 13.5 f1 (ppm) 2.04 2.06 2.09 0.96 1.00 0.94 1.05 7.39 7.41 7.41 7.49 7.50 7.51 7.52 7.52 7.53 7.56 7.58 7.60 7.90 7.90 8.18 8.19 8.20 8.21 9.88 12.80 0 10 20 30 40 50 60 70 80 90 110 130 150 170 190 210 f1 (ppm) 116.20 120.02 121.02 121.29 123.47 128.23 128.63 129.85 132.63 137.71 141.90 144.09 158.53

3-Hydroxy-4-(4-methoxyphenyl)-6-nitroquinolin-2(1H)-one (5j): 50

4-(4-Chlorophenyl)-3-hydroxy-6-nitroquinolin-2(1H)-one (5k): 51

3-Hydroxy-6-nitro-4-(4-nitrophenyl)quinolin-2(1H)-one (5l): 52

4-(4-Chlorophenyl)-8-fluoro-3-hydroxyquinolin-2(1H)-one (5m): Cl OH N O H F 5m 1 H NMR, 500 MHz 53

3-Hydroxy-6,8-dimethyl-4-phenylquinolin-2(1H)-one (5n): OH N H O 5n 1 H NMR, 500 MHz OH N H O 5n 13 C NMR, 126 MHz 180 170 160 150 140 130 120 110 100 90 f1 (ppm) 80 70 60 50 40 30 20 10 0 54

4-(4-Chlorophenyl)-3-hydroxy-6,8-dimethylquinolin-2(1H)-one (5o): 55

5,6-Dichloro-3-hydroxy-4-phenylquinolin-2(1H)-one (5p): Cl Cl OH N H O 5p 1 H NMR, 500 MHz 180 170 160 150 140 130 120 110 100 90 f1 (ppm) 80 70 60 50 40 30 20 10 0 56

57 3-Methoxy-1-methyl-4-phenylquinolin-2(1H)-one (6): 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 f1 (ppm) 2.93 3.00 1.00 0.95 1.87 1.00 4.02 3.76 3.83 7.11 7.11 7.12 7.13 7.13 7.14 7.15 7.23 7.23 7.25 7.25 7.31 7.32 7.32 7.32 7.33 7.34 7.34 7.39 7.41 7.41 7.44 7.44 7.44 7.45 7.46 7.47 7.47 7.48 7.48 7.49 7.49 7.49 7.50 7.51 7.51 7.51 7.52 7.52 7.53 7.53 7.0 7.1 7.2 7.3 7.4 7.5 7.6 f1 (ppm) 1.00 0.95 1.89 1.00 4.02 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 f1 (ppm) 29.93 60.24 114.04 121.32 122.32 127.41 128.17 128.45 128.91 129.50 133.58 137.19 137.32 145.16 159.33

4-(2-Bromophenyl)-3-hydroxy-1-methylquinolin-2(1H)-one (7): 58

(E)-N'-Benzylidene-4-methylbenzenesulfonohydrazide (8): 59